Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-06-18

European Networks of Centres of Expertise for CF (Cystic Fibrosis), LAM (Lymphangioleiomyomatosis), and LTX (Lung Transplantation)

Article Category

Article available in the following languages:

Linking clusters of experts on rare diseases

The treatment of rare diseases (RDs) requires experts and specialised infrastructure. EU-funded scientists developed a blueprint for establishing networks of expertise enabling effective treatment and improved outcome.

Health icon Health

Although expert opinions are always valued, many diseases and their therapies have become well established and most patients can be treated effectively in care facilities close to their homes. However, when it comes to RDs, the majority of the medical field is lacking experience. This is why the joined forces of experts from throughout Europe are obviously much more likely to bring about a positive patient outcome. The EU has targeted the creation of the European Networks of Centres of Expertise (ENCE) for rare diseases as one way to achieve optimal health care for European citizens. In order to develop a blueprint applicable to all RDs, the EU-funded project ENCE-CF-LAM-LTX evaluated implementation for three different RDs. Consortium members began by mapping available resources and structures separately for each of the three cases. They consulted with patients, health care workers, clinical researchers, administrators and insurers to determine needs and expectations regarding Networks of Centres of Expertise. From the research, scientists constructed a list of elemental requirements, including patient registries, clinical trials networks and the participation of patient organisations. Basic research and biobanking were also fundamental to optimised health care delivery. Each of the elemental components was then described in detail for the three RD case studies. Scientists then extracted the common characteristics among the three case studies to come up with a generic blueprint that can be applied to any RD in the future. This guiding information was published in a groundbreaking document titled 'How to build European reference networks (ERNs) for rare diseases - Elements, considerations, and materials', also referred to as 'ENCE elements'. Establishment of ENCE for rare diseases will foster even greater expertise among participants through shared knowledge and experience. This clustering of professional, support and technical resources will enable more efficient and effective patient care, improving prognoses and raising healthcare standards to the highest levels across the EU.

Discover other articles in the same domain of application